Sector dividends Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
12:05:07 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,720.50 INR | +0.34% |
|
+10.06% | +48.01% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.89% | 1.03% | 35.59x | 4.99x | 6.69x | 23.19x | 28.06x | 48.77B | |
| 1.45% | 1.53% | 17.84x | 1.98x | 2.24x | 10.09x | 12.79x | 40.67B | |
| 0.58% | 0.61% | 28x | 3.86x | 3.99x | 16.54x | 23.17x | 12.27B | |
| 0.91% | 1.04% | 27.7x | 3.06x | 3.37x | 17.45x | 22.38x | 12.11B | |
| 3.78% | 3.87% | 19.06x | 3.3x | 3.39x | 11.8x | 14.06x | 9.28B | |
| 4.51% | 5.14% | 9.6x | 1.58x | 2.21x | 5.72x | 7.01x | 7.55B | |
| 0.15% | 0.16% | 30.05x | 5.51x | 3.93x | 18.3x | 22.06x | 7.35B | |
| 3.15% | 3.11% | 16.03x | 1.33x | 2.11x | 6.82x | 9.8x | 7.3B | |
| 0.95% | 1.1% | 34.89x | 8.08x | 6.81x | 24.86x | 27.44x | 4.61B | |
| 1.7% | 1.61% | 15.9x | 0.77x | 2.19x | 9.37x | 11.85x | 4.31B | |
| 2.93% | 3.04% | 16.65x | 2.95x | 3.37x | 12.7x | 15.16x | 2.91B | |
| 3.07% | 3.48% | 19.65x | 4.99x | 5.61x | 16.81x | 18.38x | 2.54B | |
| Average | 2.01% | 2.14% | 22.58x | 3.53x | 3.83x | 14.47x | 17.68x | 13.31B | |
| Weighted average by Cap. | 1.51% | 1.63% | 25.40x | 3.52x | 4.16x | 15.83x | 19.60x |
Select your edition
All financial news and data tailored to specific country editions
